New Century Healthcare (HKG:1518) expects to have recorded an attributable profit of between 35 million yuan and 50 million yuan in 2024, down from 84.2 million yuan a year prior, a Monday filing by the healthcare provider with the Hong Kong bourse said.
The company attributed the anticipated profit slump to a sharp drop in demand for its pediatric internal medicine services in 2024.
In 2023, New Century Healthcare said it experienced a surge in patient volume driven by a widespread outbreak of pediatric infections. However, this momentum has not been sustained last year.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。